US 2004/0072253 A1Published application

Novel protein and DNA thereof

AssigneeTakeda Pharmaceutical Company Limited

InventorsYusuke Nakamura, Hirofumi Arakawa, Hiroshi Tanaka

Life of this patent

Estimating the term…

Abstract

Because the protein of the present invention has in its amino acid sequence a homology with, for example. ribonucleotide reductase, the protein of the present invention, its DNA, antibodies to these and the like are useful in the prevention, treatment and diagnosis, etc. of cancer.

Claims18

Dependent claims

A protein having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO:

1, or a salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 10/698,228Filed 30 Oct 2003
Priority: JP 017770/200021 Jan 2000
Published: 15 Apr 2004
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C12N 9/0093
Oxidoreductases: acting on CH or CH2 groups
C07K 16/30
Against receptors, cell surface antigens or cell surface determinants: from tumour cells
C07K 16/40
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against enzymes
A01K 2217/075
Animals genetically altered by homologous recombination: inducing loss of function, i.e. knock out

Family

Application10/019,733Division · filed 28 Dec 2001
Application10/019,733A 371 of international · filed 28 Dec 2001
Application10/698,228Division · filed 30 Oct 2003
US 6,682,917 B1Related patent
US 7,256,279 B2Related patent
US 2004/0072253 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results